Cargando…
Ustekinumab for steroid-refractory pancolitis in a biologically naive child: A case report and literature review
Ustekinumab is not recommended for the treatment of children with inflammatory bowel disease, but its off-label use is increasing despite a lack of pediatric pharmacokinetic data. The purpose of this review is to evaluate the therapeutic effects of Ustekinumab on children with inflammatory bowel dis...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981362/ https://www.ncbi.nlm.nih.gov/pubmed/36862878 http://dx.doi.org/10.1097/MD.0000000000033061 |